ScholarIQanswers from OpenAlex
Centro Paulista de Investigação Clinica
InstitutionResearch output, impact & collaborations
Centro Paulista de Investigação Clinica is a institution indexed in ScholarIQ from OpenAlex.
What is known about Centro Paulista de Investigação Clinica?
ScholarIQrecord summary
Centro Paulista de Investigação Clinica is a research organisation in São Paulo, BR. OpenAlex records 1,105 works and 37,572 citations for it. 444 researchers list it as their most recent affiliation.
How many works does Centro Paulista de Investigação Clinica have?
ScholarIQindexed works
Centro Paulista de Investigação Clinica has 1,105 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Centro Paulista de Investigação Clinica have?
ScholarIQcitation count
Centro Paulista de Investigação Clinica has 37,572 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Centro Paulista de Investigação Clinica?
ScholarIQresearcher count
Centro Paulista de Investigação Clinica has 444 researchers in the ScholarIQ index.
What is the average h-index at Centro Paulista de Investigação Clinica?
ScholarIQavg h-index
Centro Paulista de Investigação Clinica has an average h-index of 26.5 in OpenAlex.
What is the ROR of Centro Paulista de Investigação Clinica?
ScholarIQror
The ROR for Centro Paulista de Investigação Clinica is on the source record.
What is the OpenAlex record for Centro Paulista de Investigação Clinica?
ScholarIQopenalex
The OpenAlex for Centro Paulista de Investigação Clinica is on the source record.
Who are the most-cited researchers behind Centro Paulista de Investigação Clinica?
ScholarIQtop researchers by citations
What are the most-cited papers on Centro Paulista de Investigação Clinica?
ScholarIQmost cited works
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial
Gerd R Burmester, Ricardo Blanco, Christina Charles‐Schoeman, J. Wollenhaupt, Cristiano A. F. Zerbini, Birgitta Benda, David Gruben, Gene V. Wallenstein, Sriram Krishnaswami, Samuel H. Zwillich, Tamás Koncz, Koshika Soma, John Bradley, Charles A. Mebus
Tofacitinib (CP‐690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study
Désirée van der Heijde, Yoshiya Tanaka, Roy Fleischmann, Edward Keystone, Joel M. Kremer, Cristiano A. F. Zerbini, Myrna Cardiel, Stanley Cohen, Peter Nash, Yeong Wook Song, Dana Tegzová, Bradley T. Wyman, David Gruben, Birgitta Benda, Gene V. Wallenstein, Sriram Krishnaswami, Samuel H. Zwillich, John Bradley, Carol A. Connell, and the ORAL Scan Investigators
The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double‐blind, placebo‐controlled phase IIa trial of three dosage levels of CP‐690,550 versus placebo
Joel M. Kremer, Bradley J. Bloom, Ferdinand C. Breedveld, John Coombs, Mark P. Fletcher, David Gruben, Sriram Krishnaswami, Rubén Burgos‐Vargas, Bethanie Wilkinson, Cristiano A. F. Zerbini, Samuel H. Zwillich
Global dietary calcium intake among adults: a systematic review
Ethan M. Balk, Gaelen P. Adam, Valerie Langberg, Amy Earley, Patricia Clark, Peter R. Ebeling, Ambrish Mithal, René Rizzoli, Cristiano A. F. Zerbini, Dominique D. Pierroz, Bess Dawson‐Hughes
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study
Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos, Henry G. Bone, Bente Langdahl, Kenneth G. Saag, Ian R. Reid, Douglas P. Kiel, Ilaria Cavallari, Marc P. Bonaca, Stephen D. Wiviott, Tobias De Villiers, Ling Xu, Kurt Lippuner, Toshitaka Nakamura, Jean‐Yves Reginster, Jose Adolfo Rodriguez-Portales, C. Roux, José Zanchetta, Cristiano A. F. Zerbini, Jeong‐Gun Park, KyungAh Im, Abby Cange, Laura T. Grip, Norman Heyden, Carolyn DaSilva, Dosinda Cohn, Rachid Massaad, Boyd B. Scott, Nadia Verbruggen, Deborah M. Gurner, Deborah L. Miller, Micki L Blair, Adam B. Polis, S. Aubrey Stoch, Arthur C. Santora, Antonio Lombardi, Albert Leung, Keith D. Kaufman, Marc S. Sabatine, C. Mautalén, Z. Man, José Zanchetta, C. Magaril, Philip N. Sambrook, Jean‐Yves Reginster, Piet Geusens, Stefan Goemaere, Ben Hur Albergaria, Cristiano A. F. Zerbini, Marise Lazaretti Castro, Luiz Henrique de Gregório, Румен Стоилов, Anna-Maria I Borissova, Kiril Hristov Hristozov, Nataliya Temelkova, Ivona Daskalova, Stefka I Kuzmanova, Daniela Yaneva-Bichovska, Anastas Batalov, Pablo Riedemann, José Adolfo Rodríguez Portales, Hai Tang, Han-min Zhu, Zhenlin Zhang, Aijun Chao, Yali Hu, Zhiming Liu, Ju-ming Lu, Ming-cai Qiu, Xin Gao, Shaofen Zhang, Ling Xu, Weibo Xia, Eryuan Liao, Wenying Yang, Wen Wu, Kerong Dai, Renming Hu, Hai Tang, Juan José Jaller, Francisco Cabal, José Fernando Molina, Carlos Curé, Hernan Yupanqui-Lozno, Philippe Chalem, John Londoño, Maurício Abello, Edgardo D Tobias, William Otero, Tatjana Nikolić, Blazenka Miskic, J Štěpán, Václav Vyskočil, Libor Novosád, Jan Slesinger, Pavel Novosad, Erika Vlckova, Ladislav Bortlík, Eva Dokoupilová
How much of the research on Centro Paulista de Investigação Clinica is open access?
ScholarIQopen access share
50%OPEN ACCESS